Search Orphan Drug Designations and Approvals
-
Generic Name: | N-(tert-butylcarbamoyl)-5-cyano-2-((4'-(difluoromethoxy)-[1,1'-biphenyl]-3-yl)oxy)benzenesulfonamide |
---|---|
Date Designated: | 03/01/2018 |
Orphan Designation: | Treatment of pulmonary arterial hypertension |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
ATXA Therapeutics Limited 75 Avoca Avenue Avoca Avenue Blackrock, County Dublin Ireland The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-